Mayo Clinic is the largest integrated, not-for-profit medical group practice in the world. We're building the future, one where the best possible care is available to everyone — and more people can heal at home. Our relentless research turns into earlier diagnoses and new cures. That's how we inspire hope in those who need it most.

Learn more here

The Elimination Partnership in the Indo-Pacific for Cervical Cancer (EPICC) is a four-year (2024–2028) multi-country initiative, supported by the Australian Government and the Minderoo Foundation. EPICC is the first end-to-end program supporting Ministries of Health in the Indo-Pacific region achieve their goals to accelerate the WHO Global Strategy. Currently EPICC supports governments and partners in Fiji, Indonesia, Malaysia, Nauru, Papua New Guinea, Solomon Islands, Timor-Leste, Tuvalu, and Vanuatu to strengthen cervical cancer primary prevention, screening, and treatment. Led by the University of Sydney, EPICC is delivered in partnership with a consortium of Australian and global implementation and research partners.

The Australian Centre for the Prevention of Cervical Cancer (ACPCC) is committed to preventing cancer and infectious diseases through excellence in the provision of population health services that support screening and vaccination.

As part of our commitment, the ACPCC continues to work with Australian and international partners to achieve the World Health Organization’s goal of eliminating cervical cancer as a public health problem, primarily through vaccination.

Our team are committed to supporting the effective delivery of HPV vaccination and cervical screening programs to ensure women and people with a cervix everywhere can be free from cervical cancer. It’s anticipated that Australia will be the first country in the world to achieve this, by 2035.